Pursglove Geordan Garrett
SEC insider (Form 3/4/5 filer). CIK 0002073519. CEO and Chairman of the Board at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in BOCA RATON, FL.
Companies Pursglove Geordan Garrett has filed insider reports for
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT): Director, Officer, CEO and Chairman of the Board
- Powell Max Ltd (PMAX): Director, Officer, CEO and Chairman
- GridAI Technologies Corp. (GRDX): Director
Pursglove Geordan Garrett
CIK: 0002073519
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 1, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirect350K shares- - Apr 15, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirect350K shares- - Apr 15, 2026LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
DispositionDirectOptions to Purchase Common Stock
350K shares- - Jan 1, 2026GRDX
GridAI Technologies Corp.
AwardDirect40K shares- - Jul 3, 2025LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
AwardDirectOptions to Purchase Common Stock
350K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award | 350,000 | - | $0 | Direct |
| Apr 15, 2026 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award | 350,000 | - | $0 | Direct |
| Apr 15, 2026 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Disposition Options to Purchase Common Stock | 350,000 | - | - | Direct |
| Jan 1, 2026 |  GRDX GridAI Technologies Corp. | Award | 40,000 | - | $0 | Direct |
| Jul 3, 2025 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Award Options to Purchase Common Stock | 350,000 | - | - | Direct |
1-5 of 5 transactions